Previous studies have demonstrated that quercetin, an active ingredient in BYHW, ameliorates myocardial cell apoptosis following ischemia-reperfusion injury via the DNA-PKcs-SIRT5 pathway. This evidence concerns the gene PRKDC and ischemia reperfusion injury.